FOLX
LIVE

Serial Number

88981413

Owner

FOLX HEALTH, INC.

Attorney

Wade Savoy

First Use Date

Nov 15, 2020

Filing Date

Oct 22, 2019

Add to watchlist:

No watchlists yet
View on USPTO

FOLX Trademark

Serial Number: 88981413 • Registration: 6374523

FOLX is a trademark filed by FOLX HEALTH, INC. on October 22, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

FOLX HEALTH, INC. (4 trademarks)

ONE BOSTON PLACE, SUITE 2600
BOSTON, MA 02108

Entity Type: 03

Vybe Ventures, Inc. (3 trademarks)

81 Raymond Ave.
Somerville, MA 02144

Entity Type: 03

Trademark Details

Filing Date

October 22, 2019

Registration Date

June 1, 2021

First Use Anywhere

November 15, 2020

First Use in Commerce

November 15, 2020

Published for Opposition

August 4, 2020

Goods & Services

medical services, psychological testing and counseling services, and healthcare; medical services, psychological testing and counseling services, and healthcare for families, adults, adolescents, infants, and the Lesbian, Gay, Bisexual, Transgender, Queer or Questioning, and Intersex (LGBTQI) community; pediatric healthcare services; performing diagnosis of diseases; chemical dependency and substance abuse treatment services; counselling in the field of reproductive health; medical diagnosis and treatment of infertility; human fertility treatment services; mental health services; telemedicine services; providing an Internet website portal featuring information about medical, psychological, and healthcare products and services

personal lubricants; pharmaceuticals for the treatment of sexually transmitted diseases, erectile dysfunction, premature ejaculation, female and male sex drive, acne, hair loss, premature aging, anxiety, depression, hypertension, psychosis, autoimmune disorders, sleep disorders, infertility, substance abuse, and mental health disorders; pharmaceuticals for the treatment, prevention, and management of human immunodeficiency virus (HIV); hormone replacement therapy preparations; hormones; pharmaceutical preparations for skin care; pharmaceutical preparations for skin care containing salicylic acid; diuretics; selective aldosterone antagonists; androgen blockers; testosterone blockers; vasodilators; antacids; diarrhea medications; medicinal hair growth preparations; nausea and vomiting treatment preparations; antibiotics; antivirals; antifungal preparations; analgesics; antihistamines; anti-inflammatories; antipyretic preparations; bronchodilators; preparations for treating colds; corticosteroids; decongestants; expectorants; hypoglycemic agents; laxatives; muscle relaxants; vitamins; nutritional supplements

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 1, 2026 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 28, 2024 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 30, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 29, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 29, 2021 SUPC
DIVISIONAL PROCESSING COMPLETE
Apr 29, 2021 DPCC
USE AMENDMENT FILED
Mar 11, 2021 IUAF
DIVISIONAL REQUEST RECEIVED
Mar 11, 2021 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Mar 11, 2021 ERTD
TEAS STATEMENT OF USE RECEIVED
Mar 11, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 29, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 4, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2020 NONP
ASSIGNED TO LIE
Jun 30, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2020 CNSA
DIVISIONAL PROCESSING COMPLETE
Jun 16, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 15, 2020 AITU
TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2020 TEME
DIVISIONAL REQUEST RECEIVED
May 22, 2020 DRRR
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2020 TROA
TEAS REQUEST TO DIVIDE RECEIVED
May 22, 2020 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 30, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 30, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 30, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 28, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2019 NWOS
NEW APPLICATION ENTERED
Oct 25, 2019 NWAP